P-23: EDENT1FI: population-based screening for early-stage type 1 diabetes in children and adolescents in Portugal—results from the first 12.000 screenings
P-23: EDENT1FI: bevölkerungsbasiertes Screening auf frühes Typ-1-Diabetes bei Kindern und Jugendlichen in Portugal – Ergebnisse der ersten 12.000 Screenings
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.084 ↗Auf einen Blick
Bei 12.312 Screenings in Portugal wurden 0,32 % mit frühem Typ-1-Diabetes gefunden. Die Implementierung gelang in mehreren realen Settings.
Fragestellung
Kinder und Jugendliche mit frühem Typ-1-Diabetes durch bevölkerungsbasiertes Screening in Portugal zu identifizieren.
Methode
Teil des europäischen EDENT1FI-Programms; Screening seit September 2024 bei 3–17-Jährigen in Schule, Gesundheitswesen und Community; kapilläres Blut, ELISA, Bestätigung mit Aab-Tests und venöser Bestätigung.
Ergebnisse
12.312 Screenings; mittleres Alter 9,7 ± 3,7 Jahre; 53 % männlich; 5 % mit erstgradig Verwandtem mit T1D. 46 mit einem Aab (0,37 %), 40 mit ≥2 Aab (0,32 %); 38 in strukturierter Nachsorge, 35 Stadium 1, 3 Stadium 2.
Schlussfolgerung der Autor:innen
Die Prävalenz von frühem Typ-1-Diabetes betrug 0,32 %. Das Screening wurde in mehreren realen Settings erfolgreich umgesetzt und ermöglichte rechtzeitige Stadieneinteilung, Schulung und Überwachung.
Kernaussagen
- 0,32 % hatten frühes Typ-1-Diabetes
- 38 Kinder gingen in strukturierte Nachsorge
- Bislang keine Progression zu Stadium 3 T1D
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von R Coelho und 22 weiteren Autor:innen.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Type 1 diabetes (T1D) is a complex autoimmune disease that usually occurs without a family history. Early detection of islet autoantibodies (Aab) identifies children before clinical onset, supports progression risk assessment, and may reduce disease burden.
Objectives
To identify children and adolescents with early-stage T1D through population-based screening in Portugal.
Methods
This programme is part of the European EDENT1FI initiative, targeting 220.000 children. In Portugal, screening started in September 2024 and targets 15.000 participants aged 3–17 years across schools, healthcare, and community settings. After consent, capillary blood is analysed by ELISA 3Screen ICA (GAD, IA-2, ZnT8). Positive samples undergo confirmatory individual Aab testing, including IAA, by LIPS, followed by venous confirmation. Children with early-stage T1D undergo staging and enter a structured follow-up programme with clinical, educational, and psychological support.
Results
A total of 12.312 screenings were performed (mean age 9.7 ± 3.7 years; 53% male; 5% with a first-degree relative with T1D), mainly in schools (47%), hospital settings (29%), and sports/cultural events (21%). Overall, 46 children had a single Aab (0.37%) and 40 had ≥2 Aab (0.32%), consistent with early-stage T1D. Of these, 38 entered structured follow-up, including 35 with stage 1 and 3 with stage 2. To date, no participant has progressed to stage 3 T1D.
Conclusions
Early-stage T1D prevalence was 0.32%. Population-based screening was successfully implemented across multiple real-world settings in Portugal. Within 18 months, over 80% of the target was achieved, supporting the feasibility and diagnostic yield of large-scale pediatric screening and enabling timely staging, education, surveillance, and future access to disease-modifying therapies. EDENT1FI Consortium is funded by IHI JU grant No 101132379
Zitieren
APA
Coelho, R., Andrade, R., Espada, F., Margalha, A., Luís, M., Dingle, M., Matos, D., Soares, S., Sousa, S., Antas, C., Rolim, S., Covinhas, A., Afonso, M., Silva, M., Ribeiro, R., Correia, I., Boavida, J., Vercauteren, J., Mathieu, C., …, & consortium, E. (2026). P-23: EDENT1FI: population-based screening for early-stage type 1 diabetes in children and adolescents in Portugal—results from the first 12.000 screenings. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.084
Vancouver
Coelho R, Andrade R, Espada F, Margalha A, Luís M, Dingle M, et al. P-23: EDENT1FI: population-based screening for early-stage type 1 diabetes in children and adolescents in Portugal—results from the first 12.000 screenings. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.084
BibTeX
@article{Coelho2026,
author = {Coelho, R and Andrade, R and Espada, F and Margalha, A and Luís, M and Dingle, M and Matos, D and Soares, S and Sousa, S and Antas, C and Rolim, S and Covinhas, A and Afonso, M and Silva, M and Ribeiro, R and Correia, I and Boavida, J and Vercauteren, J and Mathieu, C and Ziegler, A -G and Raposo, J and Team, Portuguese EDENT1FI and consortium, EDENT1FI},
title = {P-23: EDENT1FI: population-based screening for early-stage type 1 diabetes in children and adolescents in Portugal—results from the first 12.000 screenings},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.084}
}
EUVIMED